Published in Neurocase on February 01, 2005
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage (2011) 5.24
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease. Neuroimage (2011) 3.47
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage (2009) 2.80
Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging (2008) 2.31
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain (2009) 1.50
Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol (2008) 1.49
A novel matrix-similarity based loss function for joint regression and classification in AD diagnosis. Neuroimage (2014) 1.36
Neurodegenerative disease diagnosis using incomplete multi-modality data via matrix shrinkage and completion. Neuroimage (2014) 1.30
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal (2013) 1.20
Principal component analysis of FDG PET in amnestic MCI. Eur J Nucl Med Mol Imaging (2008) 1.13
Prediction of cognitive decline in healthy older adults using fMRI. J Alzheimers Dis (2010) 1.12
Neuroimaging measures as endophenotypes in Alzheimer's disease. Int J Alzheimers Dis (2011) 1.04
Brain imaging in the study of Alzheimer's disease. Neuroimage (2011) 0.97
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease. Neuroimage Clin (2013) 0.96
Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol (2008) 0.95
Manifold regularized multitask feature learning for multimodality disease classification. Hum Brain Mapp (2014) 0.93
Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med (2010) 0.93
Matrix-Similarity Based Loss Function and Feature Selection for Alzheimer's Disease Diagnosis. Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit (2014) 0.93
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. Neuroimage Clin (2014) 0.91
MNESIS: towards the integration of current multisystem models of memory. Neuropsychol Rev (2008) 0.90
Neuroimaging in dementia. Neurotherapeutics (2011) 0.89
The relationship of topographical memory performance to regional neurodegeneration in Alzheimer's disease. Front Aging Neurosci (2012) 0.86
Subspace Regularized Sparse Multitask Learning for Multiclass Neurodegenerative Disease Identification. IEEE Trans Biomed Eng (2015) 0.83
Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly. Mol Imaging Biol (2009) 0.83
Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk. Biochim Biophys Acta (2011) 0.82
Semi-supervised multimodal relevance vector regression improves cognitive performance estimation from imaging and biological biomarkers. Neuroinformatics (2013) 0.82
Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment. Neuroimage Clin (2015) 0.81
Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET. J Neurol (2009) 0.81
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment. J Neural Transm (Vienna) (2012) 0.78
Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism. PLoS One (2015) 0.77
Multimodal manifold-regularized transfer learning for MCI conversion prediction. Brain Imaging Behav (2015) 0.75
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Alzheimers Res Ther (2017) 0.75
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med (2006) 12.90
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet (2005) 7.66
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol (2008) 4.12
Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport (2002) 3.31
Functional neuroimaging studies of motor recovery after stroke in adults: a review. Stroke (2003) 2.92
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet (2013) 2.62
Motor imagery: a backdoor to the motor system after stroke? Stroke (2006) 2.60
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell (2008) 2.55
Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage (2003) 2.52
TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol (2009) 2.30
Imaging of acute stroke. Lancet Neurol (2006) 2.25
Motor imagery after stroke: relating outcome to motor network connectivity. Ann Neurol (2009) 2.17
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci (2008) 2.15
Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke (2012) 2.13
How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke (2008) 2.09
What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain (2006) 2.05
Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology (2012) 2.05
Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain (2013) 2.02
Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage (2009) 1.95
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet (2010) 1.85
Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain (2008) 1.84
Phenotype associated with APP duplication in five families. Brain (2006) 1.83
Treatment of anterior communicating artery aneurysms: complementary aspects of microsurgical and endovascular procedures. J Neurosurg (2003) 1.79
Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain (2007) 1.76
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol (2004) 1.72
Post-stroke plastic reorganisation in the adult brain. Lancet Neurol (2003) 1.72
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain (2003) 1.72
Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat (2007) 1.69
The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke (2005) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. J Alzheimers Dis (2010) 1.65
Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology (2008) 1.64
Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging (2007) 1.64
Quality of life and brain damage after microsurgical clip occlusion or endovascular coil embolization for ruptured anterior communicating artery aneurysms: neuropsychological assessment. J Neurosurg (2009) 1.61
Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci (2009) 1.61
Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol (2009) 1.59
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain (2012) 1.58
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. J Alzheimers Dis (2013) 1.57
Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med (2004) 1.56
The relationship between motor deficit and hemisphere activation balance after stroke: A 3T fMRI study. Neuroimage (2006) 1.55
Working memory and executive functions in transient global amnesia. Brain (2003) 1.53
Behavioral and neurofunctional changes over time in healthy and aphasic subjects: a PET Language Activation Study. Stroke (2003) 1.51
PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain (2013) 1.51
Long-term follow-up of acute partial transverse myelitis. Arch Neurol (2012) 1.50
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet (2006) 1.50
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain (2009) 1.50
Semantic and episodic memory of music are subserved by distinct neural networks. Neuroimage (2003) 1.49
A combined neuropsychological and brain imaging study of obstructive sleep apnea. J Sleep Res (2009) 1.49
Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia. J Neurosci (2012) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J Neuroimmunol (2007) 1.47
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Is neural activation within the rescued penumbra impeded by selective neuronal loss? Brain (2013) 1.45
Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain (2010) 1.44
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
The relationships between memory systems and sleep stages. J Sleep Res (2005) 1.35
Differential effect of age on hippocampal subfields assessed using a new high-resolution 3T MR sequence. Neuroimage (2010) 1.34